Business Wire

Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced top-line results from their Phase 3 clinical trial to evaluate ...
AOL

mRNA tech could help fight cancer, but cuts threaten progress, experts say

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.
C&EN

AI-based program designs new mRNA

A spiral strand of messenger RNA, colored orange. Raina Biosciences has unveiled a new artificial intelligence–based platform for designing messenger RNA. Credit: Shutterstock A new artificial ...
Business Wire

Potential First-in-Class Data from Preclinical Program for STX-003, a Programmable mRNA Therapy to Treat Solid Tumor Cancers

Company to share updates at the AACR and ASGCT annual meetings BOSTON--(BUSINESS WIRE)--Strand Therapeutics Inc., the programmable mRNA company developing curative therapies for cancer and beyond, ...